Recently, we reported that JBOL inhibited BLM-induced IPF by regulating the release of inflammatory factors, such as IFN-γ and IL-4 (Zhang, Cui et al., 2018). This evidence concerns the gene IFNG and idiopathic pulmonary fibrosis.